The Food and Drug Administration is asking for proposals for automated devices that can provide high-definition imaging and critical analyses of drug performance as the agency works to integrate more AI.
The Food and Drug Administration is seeking public feedback amid its efforts to balance the advantages and risks of deploying artificial intelligence and machine learning into drug creation and approval processes.
The HHS published a proposed modification to HIPAA’s privacy rule, giving new protections to personal health information related to reproductive care history in the wake of Dobbs and the overturning of Roe v. Wade.
Brian Goodger, who has served as acting director of the National Institutes of Health Information Technology Acquisition and Assessment Center since 2021, will now helm the center in a permanent capacity.
A Government Accountability Office report found that the agencies responsible for managing infrastructure in the healthcare and public health, energy and transportation sectors need to better assess their cyber risk mitigation strategies.